Related Experiment Videos
Methicillin-resistant Staphylococcus aureus infection in palliative care
W Prentice1, R Dunlop, P J Armes
1St Christopher's Hospice, London, UK.
Palliative Medicine
|January 6, 2000
Summary
Methicillin-resistant Staphylococcus aureus (MRSA) infection impacts palliative care, causing significant morbidity in a few patients. MRSA also reduces bed availability due to isolation and cleaning needs, affecting hospice operations.
Area of Science:
- Infectious Diseases
- Palliative Care Medicine
- Healthcare Management
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) is a significant healthcare-associated pathogen.
- Palliative care settings present unique challenges for infection control and patient management.
Purpose of the Study:
- To evaluate the clinical impact of MRSA in palliative care patients.
- To assess the effect of MRSA on hospice bed occupancy and operational efficiency.
Main Methods:
- Retrospective review of MRSA-positive patient records across three London hospices.
- Prospective study analyzing factors influencing bed occupancy in one hospice.
Main Results:
- MRSA was present in 4-8% of admissions; 7 out of 43 MRSA patients experienced clinically significant infections.
- MRSA led to delayed admissions and reduced bed availability due to isolation and enhanced cleaning protocols.
- Identified risk factors for MRSA colonization and bacteremia were similar to the general population.
Conclusions:
- MRSA infection is associated with considerable morbidity in a subset of palliative care patients.
- The impact of MRSA on bed occupancy figures in hospices requires careful consideration to avoid underestimation.
- Further research is needed to explore the psychological and financial burden of MRSA in this population.